Quantcast
Last updated on April 18, 2014 at 5:30 EDT

Latest Coenzymes Stories

2009-08-03 09:15:31

One of the long standing problems in the drinks industry is how to prevent chemical processes in the drinks compromising their taste, quality and shelf life. In particular, riboflavin (vitamin B2) is responsible for driving photooxidation reactions that affect the flavor of many drinks and so they often have to be packaged in light-shielded containers.Now Börje Sellergren, at the Technical University of Dortmund, Germany, and colleagues have developed a way of removing riboflavin. They...

2009-07-30 15:00:00

NOVATO, Calif., July 30, /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent Office has issued patents covering stable tablet formulation and the approved once daily dosing regimen for Kuvan(R) (sapropterin dihydrochloride) for the treatment of phenylketonuria (PKU). The patent for stable tablet formulation expires in 2025, and the patent for the once daily dosing regimen expires in 2024. "We believe the issuance of these two...

8d1852f2755268034d663d20090754771
2009-07-14 09:10:00

Wild birds of several species are dying in large numbers from a paralytic disease with hitherto unknown cause in the Baltic Sea area. A research team at Stockholm University, Sweden, led by Associate Professor Lennart Balk, has demonstrated strong relationships between this disease, breeding failure, and advanced thiamine (vitamin B1) deficiency in eggs, young, and adults. The results are presented in the article "Wild birds of declining European species are dying from a thiamine deficiency...

2009-06-10 08:00:00

NOVATO, Calif., June 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received notice of priority review status for Kuvan(R) (sapropterin dihydrochloride) as an oral treatment for patients with phenylketonuria (PKU) from Health Canada. Priority review provides for a shortened submission review of 180 days versus the standard twelve months. BioMarin plans to file a marketing application for Kuvan in Canada in the third quarter of 2009, and...

2009-05-15 08:00:00

National Organization for Rare Disorders (NORD) Recognizes BioMarin's Efforts to Expand Treatment Options for Patients with PKU NOVATO, Calif., May 15 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received the 2009 Corporate Award from the National Organization for Rare Disorders (NORD), an organization dedicated to improving the lives of people with rare diseases. The award was presented on May 14 at NORD's annual "Partners in Progress"...

2009-04-24 10:05:22

University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness. Scientists believe that uveitis, an inflammation of the tissue located just below the outer surface of the eyeball, produces 10 to 15 percent of all cases of blindness in the United States, and causes even higher rates of blindness globally. The inflammation is normally treated with antibiotics...

fa32bf98a1ae2850ff3cc7fa7944a6171
2009-03-29 09:57:11

A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease. Assistant Professor of Chemistry and Biochemistry Barbara Gerratana, in the university's College of Chemical and Life Sciences, led the research team, which included her graduate student Melissa Resto...

2009-03-17 11:43:00

Company brings the latest in Italian skin care to the U.S. TURIN, Italy, March 17 /PRNewswire/ -- Direct from Italy, Perlabella PureDose Pearls bring the latest in anti-aging skin care technology to America. The skin care line offers four highly concentrated anti-aging serums: Retinol Face, Q10 Face, Vitamin C Face and Retinol Eye. "Perlabella PureDose Pearls are unique because they are airtight, making it impossible for water, air or preservatives to compromise the integrity of their...

2009-03-06 11:58:02

Personal nutrition coach and U.S. nutrition author Jack Challem is challenging a recent study on high doses of vitamin C interfering with chemotherapy drugs. Challem, a Tucson, Ariz., personal nutrition coach and a regular contributor to the journal Alternative and Complementary Therapies, challenges the findings of a study published in Cancer Research which concludes that vitamin C given to mice or cultured cells treated with common anticancer drugs reduces the tumor-fighting effects of the...

2009-02-26 11:16:00

Nutritional Supplement Offers Promising Results for Tired Baby Boomers MINNEAPOLIS, Feb. 26 /PRNewswire/ -- Bioenergy Life Science--The Ribose Company(TM)--has announced preliminary findings indicating that Bioenergy Ribose(TM) lessens fatigue among baby boomers. The results were presented at the Scripps Integrative Conference(1). Bioenergy Ribose consists of D-ribose and is a patented functional ingredient for foods and beverages as well as supplements such as Corvalen(R). In a study...